Research Associate/Associate Scientist - Cell Line Development
GC Therapeutics
Summary
GC Therapeutics is seeking a highly motivated Research Associate or Associate Scientist to join our Cell Line Development (CLD) team. This role focuses on iPSC scale-up and differentiation from benchtop to production-scale bioreactors. The ideal candidate will engineer novel cell therapy products derived from human induced pluripotent stem cells (iPSCs) for regenerative and cell-based therapies and will contribute to the development of cell line candidates for early-phase clinical trials as part of a team developing iPSC derived cellular products and related quality control assays.
Job description
Job Purpose
GC Therapeutics is seeking a highly motivated Research Associate or Associate Scientist to join our Cell Line Development (CLD) team. This role focuses on iPSC scale-up and differentiation from benchtop to production-scale bioreactors. The ideal candidate will engineer novel cell therapy products derived from human induced pluripotent stem cells (iPSCs) for regenerative and cell-based therapies and will contribute to the development of cell line candidates for early-phase clinical trials as part of a team developing iPSC derived cellular products and related quality control assays.
Duties and Responsibilities
- Culture iPSC lines including maintenance and analysis (e.g. cell culture, preparation of media, passaging, cryopreservation)
- Perform cell engineering on iPSCs to generate products for cell therapies.
- Execute experiments to optimize cell engineering processes for iPSCs and iPSC-derived cells.
- Perform, analyze and interpret experimental data, ensuring comprehensive documentation of methodologies and outcomes.
- Maintain a detailed laboratory journal, summarize results, and create presentations for internal meetings
- Troubleshoot iPSC cell line engineering challenges, improving process robustness for GMP readiness.
- Implement process changes for GMP compliance and support technology transfer to process development team.
- Contribute to the development of product characterization assays (e.g., identity, purity, potency, mechanism of action and functional assays).
- Draft and review batch records, SOPs and regulatory support documents for cell line engineering processes.
- Maintain accurate and complete records, ensuring compliance with documentation management systems.
- Collaborate with a multidisciplinary team including Analytical Development, Quality Assurance, Manufacturing, Operations, R&D, etc.
Essential Qualifications
- BS or MS degree in cell biology, biochemical or biomedical engineering, cell therapy, or a related field with 2+ years of industry experience.
- Strong expertise in iPSC culture and maintenance, cell engineering, characterization of engineered cells, and single cell cloning.
- Hands-on experience with various cell type differentiation, characterization and analysis, including flow cytometry and microscopy.
- Knowledge of iPSC 2D and 3D cultures.
- Analyze differentiated cell products.
- Optimize, refine and scale differentiation protocols for candidate cell therapeutic products.
- Experience with documentation management systems.
- Experience with working in the Controlled Non-classified Space.
- Experience in quality management system and data analysis tools.
- Solid problem-solving, analytical, and documentation skills.
- Ability to work collaboratively in a matrix organization.
- Willingness to work outside normal hours including weekends to support lab activities as needed.
Experimental Techniques
Cellular Biology: General iPSC maintenance skills (passage, cryopreservation, scale up). Execute synthetic biology-based differentiation of iPSCs. Optimize, and scale iPSC derived differentiation for therapeutic cell products. Perform assays including flow cytometry, ELISA, ICC, cell-based assays and microscopy.
Molecular Biology: Perform PCR, qPCR and ddPCR for cell characterization. Conduct genome integrity assessment and off-target characterization.
General Laboratory: Perform designed experiments, data analysis, and presentation of results to team members. Maintain detailed and well-organized records of all experimental activities. Ensure compliance with GDP, GMP, safety regulations, and company policies. Stay current on scientific advancements and contribute to innovative research.
Additional Preferred Qualifications
- Experience with operations in GMP facilities and GMP guidelines.
- Hands-on experience with ELISA.
- Experience in scale-up, process development using 3D culture, organoids and bioreactor systems.
- Experience with molecular biology tools for integration site and off-target analysis.
- Knowledge of FlowJo, next generation sequencing (NGS), bioinformatics (R, Python).
- Experience in genome integrity assessment and off-target characterization.
- Familiarity with automation, high throughput (HTP) imaging and cell cloning.
- Familiarity with relevant guidelines from the FDA, EMA and ICH.
Requirements
- BS or MS degree in cell biology, biochemical or biomedical engineering, cell therapy, or a related field
- 2+ years of industry experience
- Strong expertise in iPSC culture and maintenance, cell engineering, characterization of engineered cells, and single cell cloning
- Hands-on experience with various cell type differentiation, characterization and analysis, including flow cytometry and microscopy
- Knowledge of iPSC 2D and 3D cultures
- Experience with documentation management systems
- Experience with working in the Controlled Non-classified Space
- Experience in quality management system and data analysis tools
- Solid problem-solving, analytical, and documentation skills
- Ability to work collaboratively in a matrix organization
- Willingness to work outside normal hours including weekends to support lab activities as needed
Benefits
- Annual Bonus
- Paid Time Off
- Paid Holidays
- Medical Insurance
- Dental Insurance
- Vision Insurance
- 401(k)
- Life Insurance
- Disability Insurance
- Transportation Subsidy
- Equity Awards
Company overview
GC Therapeutics (GCTx) is a biotechnology company headquartered in Cambridge, Massachusetts, dedicated to scaling and unlocking the next generation of cell therapy-based medicines. The company was founded in 2019 based on groundbreaking research from Professor George Church's lab at Harvard Medical School and the Wyss Institute. GCTx has developed TFome™ (Transcription-Factor-ome), the world's first "plug-and-play" induced pluripotent stem cell (iPSC) cellular programming platform that integrates synthetic biology, gene editing, cell engineering, and machine learning. This innovative platform enables the rapid and efficient production of fully optimized iPSC-based cell therapies through a streamlined, single-step process that is up to 100 times faster than conventional methods, with improved potency, efficiency, quality, and cost-effectiveness. The company is advancing a pipeline of potential best-in-class cell therapy programs targeting gastrointestinal, neurological, and immunological diseases. GCTx has raised $75 million to date, including a $65 million Series A financing led by Cormorant Asset Management with participation from a16z Bio + Health, Mubadala Capital, and other leading life sciences investors.